188 related articles for article (PubMed ID: 36380167)
21. The antitumor effect of liposome-encapsulated cisplatin on rat osteosarcoma and its enhancement by caffeine.
Karita M; Tsuchiya H; Kawahara M; Kasaoka S; Tomita K
Anticancer Res; 2008; 28(3A):1449-57. PubMed ID: 18630498
[TBL] [Abstract][Full Text] [Related]
22. Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.
Susa M; Iyer AK; Ryu K; Hornicek FJ; Mankin H; Amiji MM; Duan Z
BMC Cancer; 2009 Nov; 9():399. PubMed ID: 19917123
[TBL] [Abstract][Full Text] [Related]
23. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
24. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
[TBL] [Abstract][Full Text] [Related]
25. Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy.
González-Fernández Y; Imbuluzqueta E; Patiño-García A; Blanco-Prieto MJ
Curr Pharm Des; 2015; 21(42):6104-24. PubMed ID: 26503148
[TBL] [Abstract][Full Text] [Related]
26. Lipid-coated Cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy.
Guo S; Wang Y; Miao L; Xu Z; Lin CM; Zhang Y; Huang L
ACS Nano; 2013 Nov; 7(11):9896-904. PubMed ID: 24083505
[TBL] [Abstract][Full Text] [Related]
27. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
28. Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma.
Moynihan E; Panseri S; Bassi G; Rossi A; Campodoni E; Dempsey E; Montesi M; Velasco-Torrijos T; Montagner D
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047001
[TBL] [Abstract][Full Text] [Related]
29. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
31. Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy.
Guo S; Miao L; Wang Y; Huang L
J Control Release; 2014 Jan; 174():137-42. PubMed ID: 24280262
[TBL] [Abstract][Full Text] [Related]
32. Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells.
Gui K; Zhang X; Chen F; Ge Z; Zhang S; Qi X; Sun J; Yu Z
Biomed Pharmacother; 2019 Mar; 111():751-764. PubMed ID: 30612000
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo anticancer effects of two quinoline-platinum(II) complexes on human osteosarcoma models.
Ruiz MC; Resasco A; Di Virgilio AL; Ayala M; Cavaco I; Cabrera S; Aleman J; León IE
Cancer Chemother Pharmacol; 2019 Apr; 83(4):681-692. PubMed ID: 30661096
[TBL] [Abstract][Full Text] [Related]
34. Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment.
Gu X; Ding J; Zhang Z; Li Q; Zhuang X; Chen X
Curr Pharm Des; 2015; 21(36):5187-97. PubMed ID: 26412359
[TBL] [Abstract][Full Text] [Related]
35. Carboplatin prodrug conjugated Fe
Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F
J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730
[TBL] [Abstract][Full Text] [Related]
36. Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug.
Prasad SR; Kumar TSS; Jayakrishnan A
Nanotechnology; 2018 Jan; 29(1):015101. PubMed ID: 29130895
[TBL] [Abstract][Full Text] [Related]
37. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
[TBL] [Abstract][Full Text] [Related]
38. Osteotropic therapy via targeted layer-by-layer nanoparticles.
Morton SW; Shah NJ; Quadir MA; Deng ZJ; Poon Z; Hammond PT
Adv Healthc Mater; 2014 Jun; 3(6):867-75. PubMed ID: 24124132
[TBL] [Abstract][Full Text] [Related]
39. Reduction-sensitive platinum (IV)-prodrug nano-sensitizer with an ultra-high drug loading for efficient chemo-radiotherapy of Pt-resistant cervical cancer in vivo.
Luo K; Guo W; Yu Y; Xu S; Zhou M; Xiang K; Niu K; Zhu X; Zhu G; An Z; Yu Q; Gan Z
J Control Release; 2020 Oct; 326():25-37. PubMed ID: 32531414
[TBL] [Abstract][Full Text] [Related]
40. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
